tiprankstipranks
Trending News
More News >

Dyadic International rebrands as Dyadic Applied BioSolutions

Dyadic International (DYAI) announced that, effective in 30 days, it will be doing business as Dyadic Applied BioSolutions, marking a pivotal step in the company’s transition from a research-driven organization to a commercially focused enterprise. The new name and revised visual identity reflect Dyadic’s strategic emphasis on delivering applied biotechnology solutions through its patented and proprietary C1 and Dapibus gene expression platforms. “As we evolve from licensing our technology in support of therapeutic and vaccine development into a revenue-focused bioprocessing protein platform business, our C1 and Dapibus production platforms remain the engines we expect to drive commercial execution,” said Joe Hazelton, President and Chief Operating Officer of Dyadic. “The progress on our second non-animal dairy enzyme program – which recently triggered a $250,000 milestone payment – reflects the tangible outcomes of our new focus on commercialization. This rebranding reflects our top priority to deliver high-value input proteins at commercial scale.”

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1